Exclusive Interviews

Tony Galliani is the National Sales Director at Companion Medical located in San Diego. With over 18 years of experience, Tony was previously Sales Director of the eastern U.S. at Tandem Diabetes Care. He also held positions at Minimed and Animas, a Johnson & Johnson company.

In this Exclusive Interview, Tony Galliani talks with Diabetes in Control Publisher Steve Freed during the AACE 2018 convention in Boston about InPen, a new smart pen for people who are using insulin to manage their diabetes.

In this Exclusive Interview, Tony Galliani talks with Diabetes in Control Publisher Steve Freed during the AACE 2018 convention in Boston about a new smart pen for people who are using insulin to manage their diabetes.

In part 1 of this Exclusive Interview, Tony Galliani shares an overview of a new smart insulin delivery device in a conversation with Diabetes in Control Publisher Steve Freed.

In part 2 of this Exclusive Interview, Tony Galliani talks with Diabetes in Control Publisher Steve Freed about their target market, patients who are not using insulin pumps.

In part 3 of this Exclusive Interview, Tony Galliani talks with Diabetes in Control Publisher Steve Freed about the features of the new smart pen and how it compares to pumps.

In part 4 of this Exclusive Interview, Tony Galliani talks with Diabetes in Control Publisher Steve Freed about how the smart pen works for basal-bolus injections.

In part 5 of this Exclusive Interview, Tony Galliani explains the warranty, maintenance, and insurance coverage of the new smart pen in a conversation with Diabetes in Control Publisher Steve Freed.

In part 6, the conclusion of this Exclusive Interview, Tony Galliani talks with Diabetes in Control Publisher Steve Freed about the connectivity of the InPen with other devices.

Andrea Dunaif, M.D., is the Lillian and Henry M. Stratton Professor of Molecular Medicine and Chief of the J. Lester Gabrilove Division of Endocrinology, Diabetes and Bone Disease at the Icahn School of Medicine at Mount Sinai, New York, NY. Dr. Dunaif is an internationally recognized expert in endocrinology and women’s health. Her research on polycystic ovary syndrome (PCOS), the most common hormonal disorder of reproductive-age women, has shown that it is a leading risk factor for type 2 diabetes mellitus. Further, this research has revolutionized the treatment of PCOS with insulin sensitizing drugs.